Literature DB >> 761848

Minigastrin; corrected structure and synthesis.

R A Gregory, H J Tracy, J I Harris, M J Runswick, S Moore, G W Kenner, R Ramage.   

Abstract

Evidence is presented that minigastrin is the C-terminal tetradecapeptide amide of gastrin and not the tridecapeptide amide as previously reported. Synthesis of the tetradecapeptide amide sequence, Trp-Leu-[Glu]5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-Nh2, was achieved by a series of fragment couplings which were mediated by the dicyclohexylcarbodiimide procedure in presence of either N-hydroxysuccinimide or 1-hydroxybenzotriazole. Purification of all intermediate fragments, and of the final protected tetradecapeptide amide, was by Sephadex LH-20 chromatography. Removal of the protecting groups was effected by treatment with 90% trifluoroacetic acid in the presence of a large excess of scavengers. Purification by ion-exchange chromatography afforded the pure tetradecapeptide amide. This material had full physiological activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761848     DOI: 10.1515/bchm2.1979.360.1.73

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  7 in total

1.  Gastric acid-dependent diseases: a twentieth-century revolution.

Authors:  George Sachs; Jai Moo Shin; Keith Munson; David R Scott
Journal:  Dig Dis Sci       Date:  2014-07       Impact factor: 3.199

Review 2.  Multiple forms of gastroenteropancreatic hormones.

Authors:  G B Irvine; R F Murphy
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

3.  Metabolism of heptadecapeptide gastrin in humans studied by region-specific antisera.

Authors:  S Pauwels; G J Dockray; R Walker; S Marcus
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  Reappraisal of the secretory potency and disappearance rate of pure human minigastrin.

Authors:  D C Carter; I L Taylor; J Elashoff; M I Grossman
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

Review 5.  Proton pump inhibitors: impact on glucose metabolism.

Authors:  Diana Boj-Carceller
Journal:  Endocrine       Date:  2012-08-12       Impact factor: 3.633

Review 6.  Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy.

Authors:  Jens F Rehfeld
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-12-12

7.  Post-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanism.

Authors:  J F Rehfeld; C P Hansen; A H Johnsen
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.